Profile Photo

PAIPA 2022

  • Public Group
  • 7 months, 3 weeks ago
  • 2


  • 18



Online Community Forums PAIPA 2022 LIGHT SAVING LIVES

  • This topic is empty.
  • Author
  • RotaryColombia



    Acquire equipment to treat neonates with hyperbilirubinemia (jaundice) in the Neonatal Intensive Care Unit of the San José de Buga Hospital Foundation. These teams will strengthen medical care with opportunity, quality and safety, since they will allow an early diagnosis and timely treatment of a disease that can cause permanent disability to newborns who do not receive it, improving their prognosis in the short and long term.



    The San José de Buga Hospital Foundation, a second and third level maternal and child care institution, is a reference center for pregnant women and newborns in Guadalajara de Buga, in the center and north of the department of Valle del Cauca. It cares for the population covered or not by the Colombian health system, including displaced persons, immigrants, the street population, among others.About 2000 births are attended each year. Since the opening of the neonatal ICU in September 2005, more than 8,100 newborns have been discharged, with 500 to 560 newborns discharged per year.


    Hyperbilirubinemia is an important cause of admission and the most prevalent discharge diagnosis in the neonatal ICU of the Fundación Hospital San José de Buga. In the last 3 years we have discharged more than 800 neonates with this diagnosis, that is, 260 to 270 jaundiced neonates per year. Every month between 40 to 60% of hospitalized neonates require phototherapy as treatment, the most affected being those born prematurely (80-90% have hyperbilirubinemia) and some newborns use more than one phototherapy lamp (sometimes 2 a 3) given the severity of the disease.


    This disease, if not treated, causes acute complications such as bilirubin encephalopathy, a serious neurological dysfunction caused by neuronal toxicity due to hyperbilirubinemia, but even more serious is kernicterus, which is a chronic and irreversible complication with deafness, neurodevelopmental delay and intellectual disability. which can affect 25-60% of neonates not treated adequately. With this project we can be preventing between 65 to 160 cases of kernicterus per year, that is, preventing disability in many newborns.




You must be logged in to reply to this topic.

Activity Feed